Skip to main content

Table 1 Baseline clinical characteristics

From: 3-Year outcomes after left atrial appendage closure in patients with nonvalvular atrial fibrillation: cardiomyopathy related with increased death and stroke rate

Variable

n = 673

Age (years)

66.0 ± 8.9

Male (n,%)

397 (59.0%)

BMI (kg/m2)

26.04 ± 3.75

Persistent AF (n,%)

662 (98.4%)

Clinical history

 Heart failure (n,%)

95 (14.1%)

 Hypertension (n,%)

339 (50.4%)

 Diabetes mellitus (n,%)

85 (12.6%)

 Prior stroke/TIA (n,%)

221 (32.8%)

 Coronary artery disease (n,%)

207 (30.8%)

 Ventricular Cardiomyopathy (n,%) (n,%)

36 (5.3%)

 DCM

21 (3.1%)

 HCM

15 (2.2%)

CHA2DS2-VASc score

2.92 ± 1.67

HAS-BLED score

1.54 ± 1.08

Echocardiography

 LAD (mm)

48.80 ± 5.91

 LVEDD (mm)

49.20 ± 5.24

 LVEF (%)

52.85 ± 5.14

  1. BMI: Body mass index; DCM: Dilated cardiomyopathy; HCM: Hypertrophic cardiomyopathy; LAD: left atrial diameter; LVEDD: left ventricular end-diastolic diameter; LVEF: left ventricular ejection fraction